# Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach

> **NCT03132259** · PHASE4 · UNKNOWN · sponsor: **Mahidol University** · enrollment: 124 (estimated)

## Conditions studied

- Pituitary Tumor

## Interventions

- **DRUG:** high dose dexmedethomidine
- **DRUG:** low dose dexmedethomidine

## Key facts

- **NCT ID:** NCT03132259
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2017-05
- **Final completion:** 2018-06
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03132259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03132259, "Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03132259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*